ArticleMedeniyet medical journal2025

Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients.

Mustafa Ziyad Neamah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.